comparemela.com
Home
Live Updates
Pam Mccombe - Breaking News
Pages:
Latest Breaking News On - Pam mccombe - Page 1 : comparemela.com
EpicentRx Awarded Funding from FightMND to Evaluate Therapeutic Potential of RRx-001 in Motor Neuron Disease (aka ALS)
/PRNewswire/ EpicentRx Inc. ("EpicentRx"), a late-stage biopharmaceutical company with platforms that treat and target multiple immune-mediated inflammatory.
San diego
United states
Rob henderson
Epicentrx cy
Richard gordon
Tonyr reid
Pam mccombe
Translational research institute
Queensland university of technology
Prnewswire epicentrx inc
Centre for microbiome research
Michaelj fox foundation for parkinson research
Associate professor richard gordon
Queensland university
Microbiome research
Central nervous system
vimarsana © 2020. All Rights Reserved.